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1 
General Introduction 
There are currently three major clinical categories of pathogenic Escherichia coli 
strains that cause disease in humans: gastrointestinal pathogens, urinary tract pathogens, and 
those that infect the central nervous system. The gastrointestinal tract pathogens are further 
characterized into six pathotypes: enteropathogenic E. coli (EPEC), enterotoxigenic E. coli 
(ETEC), enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC), diffusely adherent 
E. coli (DAEC), and enterohemorrhagic E. coli (EHEC). Each of these pathotypes causes 
disease by a different mechanism. The remainder of this introduction will focus mainly on 
EHEC 0157:H7 and its ability to cause intestinal disease. EHEC is responsible for a wide 
range of clinical diseases including, uncomplicated diarrhea, hemorrhagic colitis (HC), and 
hemolytic uremic syndrome (HUS). 
Thesis Format 
The organization chosen for this thesis is written in the alternate format. It includes a 
literature review and one manuscript followed by general conclusions. The manuscript has 
been submitted to the Journal of Bacteriology. 
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Literature Review 
Reservoirs 
The major reservoir for EHEC O157:H7 is ruminants such as cattle, sheep, and deer. 
However EHEC O157:H7 has been isolated from other species including wild birds, dogs, 
raccoons and swine (42). Despite the large reservoir base for EHEC, the most common 
source of infection for humans is the inadvertent contamination of food or water by ruminant 
manure (7, 5, 26, 41 ). In the United States cattle population, EHEC O157:H7 has a relatively 
low prevalence when compared to other serotypes of Shiga toxin-producing E. coli (STEC) 
(7, 15, 18, 58, 12). The estimated infectious dose of E. coli O157:H7 from contaminated food 
in humans is estimated between 10-100 cells (7, 30). The most common sources ofEHEC 
O157:H7 infections in humans include undercooked ground beef patties, unpasteurized 
beverages (apple cider and milk), raw unwashed vegetables and non-chlorinated water. 
Newborn animals acquire normal gastrointestinal flora from their dam and 
surrounding environment. One of the most prevalent bacterial species to colonize the 
intestinal tract of young animals includes pathogenic and non-pathogenic strains of E. coli. 
In adult ruminants, the presence ofEHEC O157:H7 and STEC strains in the gastrointestinal 
tract do not appear to cause clinical disease (7). On occasion, experimentally and naturally 
inoculated STEC strains will produce clinical signs of disease such as diarrhea, hemorrhagic 
colitis and attaching and effacing lesions in young calves (7, 19, 25, 46). These findings of 
STEC disease in young calves are often confounded by concurrent infections with other 
pathogenic agents such as Cryptosporidium sp., rotavirus, coronavirus, bovine viral diarrhea 
virus (BVDV), and coccidia. These additional pathogenic agents complicate the 
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interpretation and understanding of a pure STEC infection (7, 25). In general, EHEC strain 
O157:H7 is only rarely associated with naturally occurring disease in calves. When 
challenged with a high dose (10 1° CFU) of EHEC O157:H7, colostrum deprived calves 
displayed clinical disease of hemorrhagic enterocolitis and microscopically attaching and 
effacing lesions on intestinal mucosa (7, 13). Historically, the heaviest fecal shedders of 
STEC bacteria include healthy adult cattle and normal calves. 
Surveillance 
Routine surveillance and prediction of STEC shedding by cattle does not provide 
adequate protection against contamination of food items. In order to increase the food safety 
and decrease the incidence of STEC infections the implementation of, routine pasteurization 
of milk and apple cider, increasing sanitation at processing plants, and proper cooking of 
meat products has reduced the risk of transmission ( 42). Previous attempts to vaccinate 
cattle against EHEC O157:H7 have failed due to the transient shedding and the failure to 
prevent subsequent re-infection (7, 11). Another approach to reduce fecal shedding ofEHEC 
0157 :H7 includes critical evaluation of specific farm management practices. Some studies 
have indicated that EHEC shedding maybe dependent on repeated environmental exposure 
such as a common drinking tank for individual animals (7, 50). Other potential reservoirs on 
the farm such as sheep, ponies, and flies can complicate the tracing and shedding of STEC as 
noted on one particular farm (7, 23). 
Human Infections 
In 1971, the first isolate of STEC was identified in humans and the first isolate of 
EHEC was first recognized in 1982 (42, 30). Contaminated small bowel syndrome was a 
term used previously for STEC infections. In North America, the United Kingdom and Japan 
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serotype O157:H7 is the most common cause of HC and HUS, whereas in other countries 
serotype 026 and 0111 are more prominent (30). Current records do not provide accurate 
estimates of the exact number of STEC infected people since not all laboratories test for 
these organisms and not all patients seek medical advice, especially when symptoms are 
mild. A survey of human stool samples obtained from patients with diarrhea was conducted 
by the Centers for Disease Control and Prevention (CDC) indicated that in 28 states, almost 
half of the total samples contained isolates ofEHEC strain O157:H7 (42). Additional 
surveys to determine the prevalence of O157:H7 indicated that this bacterial pathogen 
represents the fourth most common pathogen found in stool samples ( 42). 
Virulence Attributes 
To fully appreciate the ability of EHEC O157:H7 to infect and produce disease in 
humans, molecular genetics have systematically discovered essential genetic factors 
associated with the production of disease. Pathogenicity is often associated with virulence 
attributes which may be encoded on plasmids, the chromosome, bacteriophages or 
pathogenicity islands (PI). One major virulence attribute of STEC is its ability to produce 
Shiga toxins, as noted by Konowalchuck et al. (3 7). Shiga toxin nomenclature originated 
from the toxin produced by Shigella dysenteriae. Shiga toxins belong to the cytotoxic 
protein family of toxins that consist of five B subunits and one A subunit. There are two 
major variants of Shiga toxins, Stx 1, which is almost identical to Shiga toxin of Shigella 
dysenteriae and Stx2 (58% amino acid sequence homology to Stxl). Shiga toxin genes are 
carried by temperate lambdoid bacteriophages ( 45). These phages are optimally induced at 
37°C by multiple host and environmental factors and this phenomenon of phage induction is 
considered to contribute to substantial increases in the amount of toxin. In order for Shiga 
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toxins to initiate disease within the host, cells must display the Gb3 (globotriaosylceramide) 
cell surface receptor. The host cell internalizes the toxin by receptor-mediated endocytosis, 
followed by fusion of toxin with lysosomes and translocation to the Golgi apparatus where it 
is incorporated into the rough endoplasmic reticulum and eventually released into the 
cytoplasm (44). Shiga toxins depurinate 28S eukaryotic rRNA which ultimately results in the 
inhibition of protein synthesis and thus killing of the cells. In humans, the vascular 
endothelium of small blood vessels especially in the digestive and urinary tracts are rich with 
Gb3 receptors. Extensive damage to the endothelial cells lining the glomerulus leads to renal 
failure and the hemolytic uremic syndrome (HUS). 
The second major virulence attribute of EHEC O157:H7 is the pathogenicity island 
(PI) termed the Locus of Enterocyte Effacement (LEE). A pathogenicity island is defined as 
a section of closely linked chromosomally-encoded virulence-associated genes. Pis are 
highly indicative of horizontal gene transfer between different species or genera that often 
include criteria such as encoding multiple virulence factors and occupying large sections of 
the genome (6). Pis regularly contain a consistent G+C content which is different from the 
rest of the genome (22, 30). The LEE ofEHEC O157:H7 is localized on a 35-kb 
chromosomal segment that encodes for a type III secretion system (TTSS). The TTSS allows 
for bacteria/host cell interaction and is one of four major secretion systems described for 
gram negative bacteria ( 4 7). The type III secretion system is highly conserved among 
attaching and effacing (A/E) groups of pathogens and its major function is to actively 
transport translocator and effector proteins across the inner and outer membranes to the 
bacterial cell surface and into the host cell cytoplasm. These translocator and effector 
proteins are responsible for the formation of A/E lesions, which are characterized by 
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effacement of the microvilli of intestinal cells, intimate adherence of bacteria and host cells 
followed by conformational changes of the host cell mediated through cytoskeletal 
rearrangements and pedestal formation (38). Previous studies have characterized five 
principal operons within LEE: LEE] (encodes ler-LEE encoded regulator), LEE2, and LEE3 
(encodes TTSS, CesAB chaperone and EspH effector), LEE4 (encodes EspA, EspD, and 
EspB ), and LEE5 (encodes intimin, Tir, and CesT chaperone) (2). 
Genetic Regulation 
The regulation of genes located within LEE is complex and multifaceted, but in 
general, the expression of LEE of EHEC and EPEC is controlled by unique global regulators. 
The most recognized global regulator is located within LEE (LEEJ) and is an H-NS paralog 
termed !er, the LEE encoded regulator. Ler is a major factor in positively regulating LEE2, 
LEE3, LEE4, LEE5, espG, and map (4). Positive and negative regulation of global regulators 
such as !er is very complex and often involves many factors associated within separate 
regulatory cascades. Individual genes are targeted to affect LEE in either a positive or 
negative regulatory role. The following is a list of genes associated with the regulation of 
!er: h-ns, ihf fis, perC, bipA, gr/A, gr!R, gad.X, hha, along with factors included in the 
quorum-sensing cascade (4, 9, 14, 17, 20, 21, 29, 35, 51 , 52, 53, 55) Many ofthese genes 
influencing !er expression are not encoded by the LEE. It has also been reported that !er has 
the ability to auto-regulate its own synthesis by binding to the LEEJ regulatory sequence in 
EPEC (4). 
Individual regulatory genes are currently studied along with the mechanisms by 
which they alter the expression of LEE. H-NS, Fis (factor for inversion stimulation) and IHF 
(integration host factor) are each categorized as small bacterial DNA-binding proteins which 
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are implicated in the regulation of virulence factors in STEC (40). H-NS has been studied the 
most of the three small DNA-binding proteins and is classified as a histone-like protein. 
Histone-like proteins are a common structural component of the chromatin in bacterial cells 
and are normally abundant in cells. H-NS binds non-specifically to intrinsically curved DNA 
and is utilized in various cellular activities including recombination, transposition and 
transcription (36). Most notably, H-NS has the ability to negatively influence the 
transcription of virulence factors in E. coli (1). Unfortunately, the complete mechanism of 
action ofN-NS is not known. 
Current data suggests that Ler can act as an anti-repressor and overcome the ability of 
H-NS to negatively effect the transcription of LEE by forming a "repressing H-NS-
nucleoprotein complex"(9). Investigations into the regulatory function of negative effectors 
of LEE have led to the discovery of Hha and H-NS proteins as functionally equivalent 
structures at the N-terminal domain (43). Hha was first described as a small protein thermo-
modulator (approximately 8-kDa) of virulence factors. This category also includes small 
protein thermo-modulators of other pathogenic bacteria such as YmoA of Yersinia 
enterocolitica. Hha is implicated in the negative regulation of a-hemolysin expression in 
EPEC ( 49) and we recently identified it as a possible substrate for the ClpXP protease. 
ClpXP is an ATP dependent protease that is ubiquitous in most bacteria. There are 
two components to ClpXP which include a peptide-degrading unit and the ATP-binding unit, 
ClpP and ClpX respectively. The clpX gene is normally transcribed in the clpXP operon but 
there is a single weak promoter for c/pXlocated between clpP and clpX(32). This protease 
is able to degrade abnormal proteins and specifically tagged normal proteins. RpoS and "A 0 
protein are two known specific targets for the ClpXP protease (32). Recent studies have 
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shown that elpXP controls the expression of type III protein secretion system by regulation 
of RpoS and GrlR (26). The role of the elpXP protease system in other pathogenic bacteria 
include the ail (attachment invasion locus) gene in Yersinia enterocolitica and the hla (alpha 
hemolysin) gene of Staphylococcus aureus (16). These proteins are expressed in response to 
stress as a part of the stress tolerance response and are actively associated with quorum-
sensing loci. 
RpoS is another major regulatory molecule that is classified as an alternative sigma 
subunit of RNA polymerase (8). RpoS regulates the general stress response in E. coli and it is 
estimated that RpoS may affect the expression of more than 50 genes (8). RpoS mediated 
regulation of virulence genes is complex. For example, GadX is a RpoS dependent system 
and as stated below GadX is associated with pch gene regulation (33). RpoS is also linked to 
other factors such as ppGpp and DksA, which are both needed for activation ofRpoS in 
stationary-phase regulation (8, 33). 
Another positive regulator of LEE in EPEe includes Pere, which is part of the Per 
operon that includes PerA and PerB. Pere is implicated in the activation of bjp genes 
encoding the formation of the pilus needed for bacteria-bacteria attachment in EPEe. There 
are at least five Pere-like homologues in EHEe and three of these homologues encode 104 
amino acid proteins (PchA, PchB, and Pche). These 104 amino acid proteins, when 
expressed from a multicopy plasmid, enhance transcription of LEE resulting in the increased 
adherence ofEHEe O157:H7 to HEp-2 cells (25). In addition, genes that act as indirect 
regulators off er have also been identified. The gadX gene, which is transcribed during acid 
stress and stationary phase growth, affects fer expression by altering the transcription of Pere 
(2). 
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BipA is characterized as another regulatory gene in STEC and is a member of the 
ribosome-binding GTPase superfamily. BipA is ubiquitous in both bacteria and plants and is 
reported to regulate both cell surface and virulence associated genes in EPEC including 
flagella and espC. The modulation of espC in a positive manner was accomplished through 
transcriptional control of !er. It is suggested that BipA controls virulence by acting at the top 
of a multi-faceted cascade or cascades in EPEC (21). Unfortunately, like many of the other 
regulatory genes of LEE the full mechanism or cascade of BipA-mediated regulation of !er is 
not elucidated. 
Quorum-sensing is a term used for describing the response of gene expression in 
bacterial cells during environmental and cell density changes. Quorum-sensing is also 
implicated in the regulation of virulence factors associated with LEE in STEC. Sperandio et 
al. discovered the regulation of LEE by the quorum-sensing autoinducer-2 (AI-2). AI-2 is a 
hormone-like compound that alters the effects of certain regulatory proteins and is encoded 
by the luxS gene. QseA (quorum-sensing Escherichia coli regulatory A) was also implicated 
in the regulation of LEE (54). The sidA gene is the E. coli homologue for the transcriptional 
regulator luxR in quorum-sensing (29). 
GlrR (L0044) and GlrA (L0043), are two recently identified negative and positive 
transcriptional regulators, respectively, of LEE in EHEC 0157:H7 (10). Salmonella enterica 
serotypes contain the only known homolog of GrlA and this homolog is a presumed product 
of an uncharacterized gene. Barba et al. noted that GrlA and Ler form a positive regulatory 
loop that controls the expression of LEE (2) and Iyoda et al. reported that the type III 
secretion system is modulated by GrlR that is regulated by the protease ClpXP (26). 
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Additional pathways that positively or negatively affect the transcription of individual 
LEE operons have also been identified. LEE4 has been an important operon to study and 
multiple regulatory factors affecting the expression of LEE4 have been identified. LEE4 
encodes for the proteins, EspA, B, and D, which are secreted by the type III secretion system. 
EspA is required for the formation of the pilus-like structure of the TTSS (3). Beltrametti 
et.al. showed that the expression of the esp genes is influenced by environmental stimuli such 
as osmolarity and temperature. Additional factors required for fine-tuning of the expression 
of LEE4 include cr5 and the H-NS proteins that, genetically map outside of the LEE 
pathogenicity island. 
The entire LEE pathogenicity island appears to be modulated mainly through global 
regulators that respond to environmental factors. These environmental factors allow bacteria 
to either up- or down-regulate the expression of genes necessary for attachment of bacterial 
cell to host and evasion of the host immune response. Further investigation of /er and 
subsequently LEE transcriptional regulation will allow understanding of the complex 
pathway of LEE expression and pathogenesis ofEHEC O157:H7. 
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Abstract 
The locus of enterocyte effacement (LEE) encoded operons (LEEJ - LEE5) enable 
enterohemorrhagic Escherichia coli (EHEC) 0157:H7 to produce attaching and effacing 
lesions on intestinal cells (A/E). We have previously reported that hha-deleted EHEC 
0157:H7 up-regulated LEE4 through increased expression of /er, the regulatory gene 
encoded by the LEE] operon. In the present study, we demonstrate that a transpositional 
insertion in clpXP abrogated the increased expression of the LEE4 in the hha-deleted strain. 
The loss of LEE4 up-regulation in an EHEC 0157:H7 /Jhha, iJclpXP mutant was restored by 
transposon insertions immediately upstream of grlR of the grlR-grlA operon, suggesting that 
Names or trade names of commercial products mentioned in this article are solely for the 
purpose of providing specific information and do not imply recommendation or endorsement 
by the US. Department of Agriculture. 
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gr!R represses the expression of LEE4 in the absence ofHha and ClpXP. RT-PCR analysis 
revealed that gr!R transcription increased by about 100-fold in strains lacking hha but 
remained the same in the presence or absence of clpXP thus indicating that hha acts as a 
negative regulator of gr!R transcription. RT-PCR data also showed a 10-fold reduction in 
LEE4 transcription for EHEC O157:H7 .dclpXP thus suggesting that the absence of clpXP 
resulted in an increased accumulation of GrlR and presumably Hha thereby causing an 
additional reduction in LEE4 transcription compared to that oberved for LEE4 in EHEC 
O157:H7. Western blot analysis of the cell-free extracts ofEHEC O157:H7 .dclpXP revealed 
increased accumulation of Hha. Altogether, the results described in this report indicate that 
ClpXP is important for maintaining a critical intracellular pool of Hha, which in tum 
modulates transcription of grlR-grlA so that a basal level of transcription could continue 
through LEE4 and the other LEE operons. 
Introduction 
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 causes a broad spectrum of 
diseases including uncomplicated diarrhea, hemorrhagic colitis (HC), and hemolytic-uremic 
syndrome (HUS) (19). One major virulence attribute ofEHEC O157:H7 is the ability to 
produce Shiga toxins encoded by genes stxl and stx2. Shiga toxins are responsible for 
producing systemic manifestations of the disease, which are characterized by acute renal 
failure, microangiopathic hemolytic anemia, and thrombocytopenia in very young and elderly 
patients (19, 24, 26). The second attribute of virulence in EHEC is the ability to attach 
intimately to the host intestinal tract and produce the characteristic histopathology lesion 
termed attaching and effacing (A/E) (30). The genes involved in the intimate colonization 
are located on a 35.6-kb pathogenicity island termed the locus of enterocyte effacement 
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(LEE) (31 ). Previous studies have characterized five principal operons within LEE: LEE] 
which encodes !er, a key positive regulator of LEE; LEE2 and LEE3 which encode the type-
III secretion system, CesAB chaperone and EspH effector; LEE4 which encodes EspA, 
EspD, and EspB; and LEE5 which encodes intimin, Tir, and CesT chaperone (7, 34). 
EHEC utilizes the type-III secretion system for the secretion of several virulence and 
effector proteins including, intimin (an outer membrane protein), Tir (translocated intimin 
receptor), and EspA, EspD, and EspB (secreted proteins). Collectively, these proteins 
promote intimate attachment of bacterial cells to host intestinal cells and subsequent 
formation of A/E lesions. A/E pathology is characterized by the loss of enterocyte microvilli 
and the formation of a polymerized actin pedestal forming a cup-like structure around the 
invading bacteria ( 6). 
The regulation of genes located within LEE is complex and multifaceted. LEE itself 
encodes several regulators such as !er (a positive regulator of LEE1-LEE5), grlA (a global 
regulator of LEE activation), and gr!R (a global regulator of LEE repression) (1 , 3, 12, 25, 
40, 41). Global regulatory systems such as Fis, BipA, H-NS, PerCl , IHF and Hha (2, 5, 12, 
18, 28, 37, 39) are located outside of LEE and interact with !er to affect the expression of 
LEE. Additionally, a quorum-sensing pathway activates transcription of qseA , a positive 
regulator of !er (18, 38, 42). 
ClpXP, a caseinolytic protease, affects LEE expression by modulating the 
intracellular levels of RpoS and GrlR (17). ClpXP is classified in a group (AAA+, ATP-
dependent proteases) that is responsible for greater than 90% of cellular proteolysis, ( 4, 9, 14, 
20, 21, 22, 27). Other proteases in this category include Lon, ClpAP, and HslVU (21). 
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We have recently reported that EHEC O157:H7 LJhha showed enhanced expression of 
LEE4 and other LEE-encoded operons via the up-regulation of LEE activator fer (37). In this 
paper, we describe experiments to demonstrate that clpXP-mediated regulation of GrlR is 
responsible for the enhanced expression of LEE4 and fer in EHEC O157:H7.LJhha. In 
addition, we also describe experiments to show that hha functions as a negative regulator of 
grfR-grfA operon and accumulation of Hha in EHEC O157:H7 LJclpXP caused reduced 
expression of LEE4. Based on the data presented in this study, we have proposed a model to 
illustrate the role of clpXP, hha, grfR, and grfA in the expression of LEE-encoded genes. 
Methods 
Bacterial strains, plasmids, and growth conditions. Table 1 lists bacterial strains and 
plasmids used in this study. Luria-Bertani (LB) agar and LB broth were used for bacterial 
growth. Ampicillin (50 mg r1), kanamycin (50 mg r1), zeocin (25 mg r1) , and 5-bromo-4-
chloro-3-indolyl-~-D-galactopyranoside (X-gal) (40 mg r1) were added to the media as 
needed. 
Primer design, PCR amplification, and DNA sequencing. Primers used for isolating specific 
nucleotide sequences and for determining relative abundance of gene-specific transcripts by 
RT-PCR are listed in Table 2. EHEC O157:H7 EDL933 genome was used as reference for 
selecting these primers (35). Primers were synthesized by Integrated DNA Technologies 
(Coralville, IA). PCR amplifications of DNA :s; 2 kb were performed using 25 µl reactions, 
containing 2.5 µl DNA (0.1 µg) , 1 µl each of forward and reverse primers (0.3 µM), and 20.5 
µl of AmpliTaq Gold master mix (PE Biosystems, Foster City, CA). DNA fragments:?: 2 kb 
were amplified using the Failsafe PCR kit (Epicenter Technologies, Madison, WI). PCR 
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products were resolved on agarose gels and DNA fragments of predicted sizes were purified 
from agarose slices using the QIAquick Gel Extraction Kit (QIAGEN, Inc, Valencia, CA). 
DNA sequencing analysis was performed either at the DNA Sequencing and Synthesis 
Facility at the Iowa State University (Ames, IA) or by the DNA sequencing facility at the 
National Animal Disease Center (Ames, IA). 
Construction of LEE4::lac transcriptional fusion. LEE4::lac fusion was constructed and 
introduced into the chromosome ofEHEC O157:H7 strain 86-24 !::.stx2/1lac by the method 
described previously (37). 
Transposon mutagenesis. EHEC O157:H7 strain 86-24 !::.stx211lac11hha LEE4::lac was 
electroporated with EZ::Tn<Kan-2>Tnp transposon (Epicenter Technologies, Madison, WI). 
Following incubation for 1 h in SOC broth, electroporated cells were plated on LB agar 
plates containing kanamycin and X-gal. After an overnight incubation at 37°C, plates were 
visually examined for the presence of colonies that were either dark blue or white in color. 
The amount of p-galactosidase produced by selected dark blue colonies was compared to the 
amount produced by the parent strain. White colonies were not selected for further studies 
because these colonies invariably resulted from transposon insertion in the lac cassette. 
Quantification of p-galactosidase activity (quantitative colorimetric assay). Standard 
methods were used to determine p-galactosidase activity (29). Overnight cultures were 
diluted 1: 100 in LB broth, incubated at 3 7°C for up to six hours (growth period long enough 
to detect near maximal LEE activity), and then assayed for P-galactosidase activity as 
described previously (37). 
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Identification of transposon insertion sites. Location of transposon insertion in the bacterial 
chromosome and the nucleotide sequence of the DNA flanking the insertion sites were 
determined by a previously described method (37). 
Construction of in-frame clpXP deletion. To generate an in-frame deletion of clpXP, a 1.5-
kb sequence located upstream (US) and a 1.5-kb sequence located downstream (DS) of 
clpXP were amplified by PCR from EHEC O157:H7 86-24 by using primers sets VS449-
XbalNS450Sall and VS451-Sall/ VS452Xbal (Table 2). These fragments were cloned in 
pCRXL TOPO TA cloning vector (In Vitrogen, Carlsbad, CA) to generate plasmid pSM222 
and pSM223, respectively. The 1.5-kb DS fragment was isolated from pSM222 and cloned 
at the 3' end of the 1.5-kb US fragment present in pSM223 to construct plasmid pSM224. 
The 3-kb US-DS fragment ofpSM224 was isolated usingXbal and cloned at theXbal site of 
the temperature-sensitive plasmid pAM450 to generate a recombinant plasmid pSM225. 
Plasmid pSM225 was electroporated into EHEC 86-24 L1stx2 iliac strain and the new strain 
86-24 L1stx2 L1lac/pSM225 was cultured under growth conditions, as described previously 
(37), that facilitated deletion of the chromosomal copy of clpXP. Deletion of clpXP from the 
chromosome of the host strain was verified by PCR using primers VS418/VS421. The 
clpXP-deleted strain produced a 200-bp band with these primers indicating the deletion of the 
entire 3.24-kb clpXP operon (data not shown). 
Complementation with multi-copy plasmids. The ORFs corresponding to disrupted genes 
(clpP or clpXP or gr!R) were isolated by PCR using primers listed in Table 2. The 1.2-kb 
clpP and 2.4-kb clpXP ORFs were cloned into pCR2. l (In Vitrogen, Carlsbad, CA) to 
generate plasmids pSM201 and pSM202, respectively. The 0.42-kb gr!R ORF was cloned 
into pCRXL to produce plasmid pSM270. The complementation plasmids were 
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electroporated into E. coli ToplO electrocompetent cells (InVitrogen, Carlsbad, CA). 
Recombinant plasmids carrying cloned copies of specific ORF were isolated and transformed 
into strains containing a Tn-Kn-disrupted copy of the corresponding ORF in the 
chromosome. Degree of complementation, conferred by the plasmid-borne ORF, in the host 
strain was measured by comparing the p-galactosidase activity of the complemented versus 
un-complemented strain. 
Purification of proteins. The method for cloning of the hha ORF in pGEX-4T-3 (Amersham 
Pharmacia Biotech Inc., Piscataway, N.J.) to produce GST (glutathione S-transferase)-Hha 
fusion protein and isolation of Hha moiety by thrombin treatment from the fusion protein has 
been reported in a previous publication (3 7). 
Reverse-transcription polymerase chain reaction (RT-PCR) analysis. Total RNA was 
prepared by using RNAeasy Kit (QIAGEN, Inc, Valencia, CA). Contaminating DNA was 
removed from RNA preparations by using a commercially available DNA removal kit 
(Ambion, Inc, Austin, TX). Recovered RNA was analyzed on an agarose gel to determine 
the presence of distinct 23S and 16S rRNA bands. RNA concentration was determined by 
using NanoDrop Spectrophotometer (NanoDrop Technologies, Inc, Wilmington, DE). A 
single-step RT-PCR kit was used for converting RNA into cDNA and amplifying cDNA into 
double-stranded DNA (PE Biosystems, Foster City, CA). The primer sets VS319NS320, 
VS323NS324, VS376NS377, VS587NS588, and VS589NS590 facilitated detection of 
amplicons specific to gapA, espA , !er, gr!R, and gr/A , respectively (Table 2). Primers used 
for detecting gapA, espA, and !er have been described in a previous publication (37). The 
samples were analyzed on a 4% Nusieve agarose gel containing ethidium bromide (Cambrex 
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Corporation, East Rutherford, NJ) and the gel was visualized using Alpha Innotech Image 
documentation system (Alpha Innotech Corporation, San Leandro, CA.). 
Immunization of rabbits. Seven New Zealand White, female rabbits ( 4 kg each) were sedated 
with an intra-muscular (IM) injection of 10 mg per ml of acepromazine (Phoenix 
Pharmaceutical, St. Joseph, MO) prior to bleeding and antigen (GST-Hha) injection (GST-
Hha). A pre-immune serum sample ( control) was collected from the marginal ear vein prior 
to injecting the animal with the antigen (0.5 mg of antigen mixed with Freund's incomplete 
adjuvant) in thigh muscles. Booster shots of the antigen alone were administered at 2 and 4 
weeks post initial injection. Blood was collected on day 36 to detect the level of specific 
antibody in the sera. Rabbits were sedated with Ketamine (35mg/kg BW)/Xylazine (2mg/kg 
BW) combination prior to exsanguination by cardiac puncture on day 50. Approximately 60 
ml of blood was harvested thus resulting in 40 ml of serum per rabbit. Relative levels of the 
anti-Hha antibody titers in rabbit antisera were determined by using a commercially available 
ELISA kit (Kirkegaard & Perry Laboratories, Inc, Gaithersburg, MD). In brief, 100 µl of 
coating buffer containing Hha at 10 µg per ml was applied to each well of an ELISA plate. 
The post and pre-inoculation sera were diluted at concentrations of 1, 10-1, 10-2, 10-3, 104 per 
ml before adding to the Hha-coated wells. These plates were processed according to 
manufacturer's instructions (KPL, Gaithersburg, MD). This procedure produced a positive 
signal with 10-4 dilutions of serum samples indicating very high titers for anti-Hha antibodies 
in rabbit sera (data not shown). 
Western immunobloting. Strains were grown overnight from a single colony. The overnight 
culture was diluted 1: 100 in fresh LB broth. After incubation at 37°C for 6 hours, cells were 
harvested at 6,000 x g for 5 min. The pellet was resuspended in 10 ml of PBS containing 
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1mg of lysozyme, incubated on ice (10 min), sonicated (20 second pulses for one to two 
minutes), and centrifuged at 12,000 x g (10 minutes) to remove unbroken cells and cell 
debris. The supernatant was analyzed for protein content by using the Bio-Rad protein assay 
kit (Bio-Rad, Hercules, CA). Samples containing approximately 0.03 mg of total protein 
were resolved on a 15% pre-cast SDS polyacrylamide gel (Bio-Rad, Hercules, CA). Proteins 
from the gel were transferred overnight (30V and 90mA) to a nitrocellulose membrane using 
the Bio-Rad Mini Trans-Blot system (Bio-Rad, Hercules, CA). A Western immunoblotting 
kit (KPL, Gaithersburg, MD) was used for detecting relative amounts ofHha in different 
strains. The membrane was first incubated in a blocking buffer for 1 h, followed by 
incubation in rabbit anti-Hha ( diluted 1: 10 in blocking buffer) antibodies for 1 h. The 
membrane was washed, incubated with HRP-conjugated goat-anti-rabbit-antibody, and 
treated with HRP substrate according to the instructions of the kit (KPL, Inc., Gaithersburg, 
MD). 
Results 
Isolation and characterization of transposon mutants exhibiting reduced expression of LEE4 
(espA)::lac fusion in EHEC O157:H7 LJ.hha. We have previously shown that the deletion of 
hha in EHEC O157:H7 (strain 86-24) resulted in the enhanced expression P-galactosidase 
activity from the LEE4::lac transcriptional fusion. Other LEE operons also exhibited 
substantial increases in their transcription in this strain (37). These increases in the 
transcriptional activities of LEE4 and other LEE operons resulted from the enhanced 
expression of ler in the absence of hha. In order to identify regulatory factors responsible for 
the elevated expression of LEE4::lac fusion, strain VKS06 (EHEC O157:H7 strain 86-24 
LJ.hha containing LEE4::lac fusion) was subjected to transposon mutagenesis. Three pale 
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blue colonies were visually identified amongst the majority of the dark blue colonies that 
grew on LB agar plates supplemented with kanamycin and X-gal. Figure 1 shows the 
amount of p-galactosidase activity produced by one of the pale blue isolates (VKS07) 
relative to the parent strain (VKS06) in the quantitative colorimetric assay. The strain 
VKS07 demonstrated p-galactosidase activity (22.4 units/OD6oo) that was 48-fold less than 
the parent strain (1075.6 units/OD6oo) indicating that a transposon insertion had disrupted a 
gene encoding a factor essential for maintaining elevated expression of LEE4::lac fusion 
Fig. 1 also shows that the level of p-galactosidase activity produced by the TN-KN mutant 
VKS07 was similar to that produced by the strain VKS05 expressing hha. Nucleotide 
sequence analysis of the DNA flanking the transposon insertion site in the mutant strain 
VKS07 revealed that the transposon had inserted 30-bp upstream from the 3' end of the clpP 
ORF of the clpXP operon. 
Complementation of mutants carrying disrupted clpP with a plasmid cloned copy of clpP or 
clpXP. Since ClpXP is implicated in virulence control in Streptococcus pneumoniae (23), 
Staphylococcus aureus (10), Escherichia coli O157:H7 (36,43), and Yersinia pestis (17, 33), 
we wanted to understand the mechanism by which ClpXP facilitated enhanced expression of 
LEE-encoded virulence genes in EHEC O157:H7 lacking hha. First, we wanted to ascertain 
that the reduced expression of LEE4::lac fusion in EHEC O157:H7 iJhha resulted from 
transpositional inactivation of clpP and not due to the polar effect on the expression of genes 
downstream of clpXP operon. For this, plasmid pSM201 (harboring clpP ORF) or pSM202 
(harboring both clpP and clpXORFs) were introduced in to the mutant strain VKS07. As 
shown in Fig. 1, transformation of pSM201 or pSM202 restored p-galactosidase activity of 
the mutant strain VKS07 to the levels that were equivalent to 62% (667.7 units/OD6oo) or 
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74% (804.7 units/OD600), respectively, of the activity expressed by VKS06 (1075.6 
units/OD600). Transformation of vector alone (pCR2.1), however, did not bring any 
significant change in the p-galactosidase activity of strain VKS07. These results indicated 
that clpP is required for maintaining high levels of LEE4:: lac expression in the absence of 
hha. In other words, absence of ClpXP and Hha in EHEC O157:H7 could potentially allow 
either the enhanced accumulation and/or expression of another repressor that reduced the 
expression of the LEE4::lac fusion to very low levels. 
Identification of the gene encoding a repressor of LEE4::lac expression in the absence of 
clpXP and hha. To identify the gene encoding a repressor of LEE4::lac expression in the 
absence of clpXP and hha, the clpXP operon was deleted from strain VKS06 to construct 
strain VKS08. As shown in Fig. 2, VKS08 produced very low levels of p-galactosidase 
activity (26.6 units/OD600), that is levels similar to that produced by VKS07 (Fig. 1 ). The 
strain VKS08 was then subjected to transposon (TN-KN) mutagenesis to identify insertion 
mutants that have their p-galactosidase activity restored to the same high level as was 
expressed in VKS06. Among 3000 kanamycin-resistant colonies, 10 colonies were found to 
exhibit darker shade of blue color on LB agar plates supplemented with kanamycin and X-
gal. However, when these transposon mutants were tested using quantitative colorimetric 
assay, only two isolates (isolate #3 and #6) showed p-galactosidase activity levels that were 
significantly higher (isolate #3, 200-fold; isolate #6, 800-fold) than VKS08. Genomic DNA 
from isolate #3 and #6 was fragmented with Eco RI and cloned in pUC 18 for isolation of 
kanamycin-resistant (i.e. transposon-bearing) colonies. Nucleotide sequence analysis of the 
plasmid DNA revealed that four kanamycin-resistant isolates that originated from transposon 
mutant #6 had transposon insertion in the promoter region of gr!R ( 4 of 6 isolates) and the 
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two isolates that originated from the mutant #3 contained transposon insertion in the 
sequence that had no homology to the nucleotide sequences in the NCBI's database (2 of 6 
isolates). The mutants containing transposon insertion in gr!R were named VKS09. 
Complementation of transposon-disrupted grlR mutant with a plasmid-cloned copy of grlR. 
Since grlR (LEE-encoded first gene of grlR-grlA operon) has been shown to cause 
repression of !er in Citrobacter rodentium and EHEC O157:H7 (5, 13, 25), we wanted to 
demonstrate whether the loss of gr!R function was the major reason behind restoration of 
hyperexpression of LEE4::lac fusion in strain VKS09. For this, the complete grlR ORF was 
isolated by PCR and cloned into pCRXL TOPO TA cloning vector system to construct 
plasmid pSM270. As shown in Figure 2, strain VKS09 containing disrupted grlR produced 
2248.1 units of p-galactosidase activity that was 48.1-fold higher than that produced by 
VKS08 (26.6 units/OD600). Addition of plasmid pSM270 into strain VKS09, however, 
reduced P-galactosidase activity of this strain to 24.4 units/OD6oo- This reduction was 
equivalent to the activity produced in the parent strain VKS08 (26.6 units/OD600) thus 
indicating that grlR acts as a negative regulator of LEE4 expression in the absence of hha and 
clpXP. 
Effect of clpXP and hha on transcriptional levels of gr!R and gr/A. According to a recent 
report, grlR and gr/A encode for a repressor (GrlR) and an activator (GrlA) of !er, 
respectively, and these two genes constitute an operon that is located with in the LEE region 
(1). In an attempt to understand the mechanisms by which clpXP and hha affectgrlR-grlA 
expression, we used 10-fold serially-diluted RNA from EHEC O157:H7 strain VKS0l (hha + 
clpXP+), VKS02 (!1hha clpXP+), VKS03 (hha+ 11clpXP), and VKS04 (11hha !1clpXP) in RT-
PCR assays to determine transcriptional levels of gr!R and gr/A. As shown in Fig. 3, 
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transcriptional levels of grlR and grlA were increased by 100-fold in VKS02 (lanes 1-4) in 
comparison to the transcriptional levels produced for these two genes in VKS0 1 and VKS03 
(lanes 1 and 2). These results indicated that Hha acts as a repressor of grlR-grlA expression 
regardless of the presence or absence of clpXP. Interestingly, transcriptional levels for both 
grlR and grlA were 10-fold lower in strain 86-24 lacking both hha and clpXP compared to 
those observed in hha-negative but clpXP-positive strain. This observation would suggest 
that the double deletion allows accumulation of another repressor that reduces transcriptional 
increases of grlR-grlA from 100-fold (observed in VKS02) to 10-fold (VKS04). 
Effect of increased expression of grlR-grlA on the expression of LEE4 and ler. Based on the 
RT-PCR data described in Fig. 3, we concluded that the expression of grlR and gr/A is 
negatively regulated by hha because increased transcription of grlR-grlA occurred in strain 
VKS02 (L1hha). However, total increases of grlR-grlA transcription in the hha-negative 
strain were also affected by the presence or absence of clpXP. For example, grlR-grlA 
transcription increased by about 100-fold in VKS02 (&ha clpXP+) while only a 10-fold 
increase was noticed for grlR-grlA transcription in strain VKS04 (L1hha L1clpXP) (Fig. 3). To 
determine whether increased transcription of grlR-grlA in hha-negative strain would affect 
the expression of LEE4 and !er, we used RT-PCR to detect levels of !er- and LEE4-
(measured by detecting espA, the very first gene in the LEE4 operon) specific amplification 
products in strain VKS02 (&ha) carrying or lacking clpXP. As shown in Fig. 4, the levels of 
a control gene gapA were identical in all four strains. On the other hand, strain VKS02 
(b,.hha clpXP+) showed increases of~ 100-fold (lanes 1-5) and~ 10-fold (lanes 1-3) for 
LEE4- and /er-specific amplification products, respectively, relative to the transcriptional 
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levels observed for LEE4 (lanes 1-3) and fer (lanes 1-2) in the parent strain VKS0l. Thus, 
these results indicated that increased transcriptional levels of grlR-grlA in the hha-negative 
strain did not abolish increased expression of fer and LEE4 presumably because the presence 
of ClpXP in this strain maintained GrlR at levels unable to reduce hyperexpression of ler and 
LEE4. However, no differences in the fer expression could be detected in VKS03 (hha + 
11.clpXP) or VKS04 (L1hha + 11.clpXP) relative to the fer expression in the parent strain. 
Interestingly, however, transcriptional levels of LEE4 were 10-fold lower in VKS03 (hha + 
11.clpXP (Fig. 4) than the levels of LEE4 in VKS0l while the transcriptional levels of grlR-
grlA in VKS03 were identical to the levels produced in VKS0l (clpXP+ hha +) (Fig. 3). 
These results suggest that the lack of clpXP presumably allows not only GrlR but also Hha to 
accumulate, thereby causing a more robust repression of LEE4 in a strain deleted of clpXP 
versus a strain expressing clpXP. 
Accumulation of Hha in clpXP deletion mutants. It has been shown in previous studies that 
the accumulation of GrlR and RpoS in clpXP-deleted strains ofEHEC O157:H7 causes 
repression of fer and /er-regulated LEE operons (16). Having demonstrated that Hha acts as 
a negative regulator of grlR-grlA (current study) and LEE4 (37), we further investigated if 
the lack of clpXP in strain VKS03 is responsible for increased accumulation of Hha and 
enhanced repression of LEE4. For this, cell-free extracts from strain VKS0I (hha + clpXP+), 
VKS02 (11.hha + clpXP+), VKS03 (hha + 11.clpXP), and VKS04 (11.hha 11.clpXP), were resolved 
on a 15% SDS-PAGE. The proteins from the gel were transferred to a nitrocellulose 
membrane and the membrane was probed with an anti-Hha antibody. As shown in Fig. 5, a 
protein band identical to Hha in size could only be detected in strain VKS03 lacking clpXP. 
In addition, the relative location of this protein band on the membrane was identical to that 
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occupied by the purified Hha in the control lane, indicating that the strain lacking clpXP did 
accumulate Hha. The inability to detect Hha in the parent 86-24 hha + clpXP+ strain could be 
attributed to the presence of very low levels of Hha, which were below the detection limits of 
the immunoassay used in this study. 
Discussion 
The most important prerequisite for EHEC 0157:H7 and other related pathogens 
inflicting A/E lesions on intestinal epithelium is the activation of LEE that encodes factors 
mediating A/E lesion formation. The expression of !er, the key positive regulator of LEE, is 
controlled by a myriad of positive and negative regulatory factors as described in this 
manuscript. Two important negative regulators of !er include hha and gr!R, with the former 
serving as a LEE-independent regulator and the latter functioning as a LEE-encoded 
regulator (25, 37). Both genes appeared to be required for maintaining LEE expression to a 
basal minimum, which is a reasonable strategy for EHEC not to expend its energy expressing 
LEE at higher levels until the pathogen is in the right niche of the host that provides 
environmental signals conducive for up-regulation of LEE. Recent studies have implicated 
that the AAA+ protease ClpXP might be a critical component of regulatory cascade that 
controls the level of negative regulator, such as gr!R, to upregulate LEE expression under 
appropriate conditions (17). In pathogens like Yersinia pestis, ClpXP and Lon protease 
coordinately control the expression of type-III secretion system by regulating the stability of 
YmoA, a small histone-like protein similar to Hha in E. coli (17). ClpXP has also been 
shown to regulate the expression of a-hemolysin (hly) in E. coli and quorum-sensing locus 
agr that regulates the stress tolerance in Staphylococcus aureus (11, 15). 
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We have previously reported that Hha exhibits specific binding in in vitro assays to 
the !er promoter and that Hha-/er promoter interactions presumably are responsible for the 
reduced transcription of !er and /er-regulated LEE operons (37). The interactions between 
Hha and its target promoters also form the basis for Hha-mediated reduced transcription of 
virulence gene-regulator hi/A in Salmonella typhimurium (8) and for the expression of 
hemolysins in E. coli pathotypes causing extraintestinal infections in humans (32). 
In the present study, we provide experimental evidence illustrating that ClpXP is 
required for LEE expression because disruption of clpXP in Hha-deficient EHEC O157:H7 
resulted in a dramatic reduction of LEE4 expression. This repression could be restored to 
wild-type levels by providing clpXP in trans. These observations suggest that the absence of 
ClpXP and Hha allowed another repressor to accumulate and /or express to levels capable of 
causing strong repression of LEE4. By screening a library of transposon mutants generated 
in VKS04 (!!.clpXP !ihha), we found elevated expression of LEE4 in mutants containing 
transposon insertions immediately upstream of the start codon of gr!R. This suggested that 
gr!R must be expressed at higher levels in strains deleted of both clpXP and hha. Using RT-
PCR, we were able to show that the absence of hha resulted in the detection of at least 100-
fold higher levels of gr!R- and gr/A-specific amplicons compared to the levels of the same 
amplicons in the hha + strain. However, the presence or absence of clpXP had no effect on 
the transcriptional levels of gr!R and gr/A. These results concur with the findings of a study 
describing that the GrlR protein is a potential direct or indirect substrate in the pathway of 
ClpXP-mediated regulation of LEE in EHEC O157:H7 (16). 
Additional evidence supporting the negative role of hha in the transcriptional 
regulation of gr!R and gr/A was obtained from experiments in which RT-PCR was used to 
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compare the levels of !er- and LEE4 (espA)- specific amplicons in strains carrying or lacking 
hha or clpXP or both. According to the R T-PCR results, the strains lacking hha showed 
about 100-fold and 10-fold increases in the transcriptional levels of LEE4 and !er, 
respectively. On the other hand, transcriptional levels of LEE4 were 10-fold lower in the 
hha-positive but clpXP-deleted strain relative to the expression of LEE4 in the parent strain 
possessing both hha and clpXP. These observations provided the basis for the following two 
conclusions. First, in absence of hha, gr!R is presumably transcribed at higher levels but the 
presence of ClpXP protease does not allow GrlR to accumulate to levels high enough to have 
a significant negative affect on the hyperexpression of LEE4 and !er. Second, the absence of 
clpXP, however, results in accumulation ofHha (as described in the present study) and GrlR 
(16) despite the fact the Hha reduces transcription of gr!R. The increased intracellular levels 
of Hha ( and presumably GrlR) might explain why the transcriptional levels of LEE4 were 
lower in the hha + strain lacking clpXP compared to the levels of LEE4 detected in the strain 
wild-type for both clpXP and hha. Although a recent report has described that ClpXP 
promotes LEE4 expression by controlling levels of GrlR and RpoS (16) in EHEC O157:H7 
Sakai strain, our study provides novel evidence that ClpXP-mediated regulation of 
intracellular levels of Hha might be a the part of a cascade controlling expression of the gr!R-
gr!A operon. The data obtained by the Western blot analysis of the cell-free extracts 
confirmed that Hha accumulated in EHEC O157:H7 lacking clpXP. Based on the data 
provided in this report and previously published studies (1 , 16, 37, 43), we propose a two-
part model for the mechanism by which Hha, ClpXP, GrlR, and GrlA modulate expression of 
!er and /er-regulated LEE ofEHEC O157:H7 (Fig. 6). The first part of the model depicts 
that the steady state expression or the basal level expression of !er and LEE by ClpXP is 
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accomplished by maintaining certain minimal (basal) intracellular amounts of Hha and GrlR. 
Since the intracellular levels of GrlA (which induces the expression of /er) are not affected 
by ClpXP (1), low level transcription from the /er promoter would ensue resulting in the 
steady state expression of /er and LEE genes. However, in strains lacking hha, ClpXP 
activity would presumably prohibit accumulation of GrlR despite a 100-fold increase in the 
transcription of gr/R. A 100-fold increase in the transcriptional level of gr/A in the hha-
negative strain, on the other hand, will presumably enhance intracellular levels of GrlA that 
would facilitate hyperexpression of /er and /er-regulated genes. 
In summary, the results reported in this study indicate that ClpXP is one of the key 
positive regulators that modulate expression of LEE-encoded genes by controlling 
intracellular levels ofHha in EHEC O157:H7. There appears to be hierarchy among Hha and 
GrlR and, based on the data provided in this and a previously published report (37), Hha 
represents the major negative regulator of LEE expression as it not only controls /er 
expression through its direct interactions with the /er promoter but also down-regulates 
expression of gr/R-gr/A operon. What remains to be investigated is whether Hha interacts 
with the gr/R-gr/A promoter in order to repress gr/R-gr/A transcription, whether Hha or GrlR 
or both serve as direct substrates for ClpXP, and if the levels of either or both of these 
repressors are affected by RpoS, which is also regulated by ClpXP. 
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Table 1. Bacterial strains and plasmidsa 
Strain Relevant genotype and description Source or Reference 
EHEC 86-24 stx2+ EHEC O157:H7, strain 86-24 34 
VKS0l 86-24 deleted of stx2 and lac 34 
VKS02 86-24 !lstx2 Mac deleted of hha 34 
VKS03 86-24 !lstx2 Mac deleted of clpXP This study 
VKS04 86-24 !lstx2 !'!lac !'!hha deleted of clpXP This study 
VKS05 86-24 !lstx2 !'!lac containing 
LEE4::lac transcriptional fusion 34 
VKS06 86-24 !lstx2 !'!lac !'!hha containing 
LEE4::lac transcriptional fusion 34 
VKS07 86-24 !lstx2 !'!lac !'!hha LEE4::lac 
containing transposon insertion in clpP This study 
VKS08 86-24 !lstx2 Mac tihha LEE4::lac 
deleted of clpXP This study 
VKS09 86-24 !lstx2 Mac !'!hha LEE4::lac containing 
transposon insertion in grlR promoter This study 
E. coli TOP 10 end.Al recAJ hsd Rl 7(rk-mk-) supE44 
<j>80dlacZ !1MI5!1(lacZYA-argF) Invitrogen 
Plasmids 
pSM201 pCR2.1 containing clpP This study 
44 
pSM202 pCR2.1 containing clpXP This study 
pSM222 pCRXL containing 1.5 kb sequence 
located 5' of clpXP (US sequence) This study 
pSM223 pCRXL containing 1.5 kb sequence 
located 3' of clpXP (DS sequence) This study 
pSM224 pCRXL containing 3 kb US-DS fragment 
( constructed by ligating 1. 5 kb DS sequence 
of pSM223 at the 3' end of 1.5 kb US sequence 
present in pSM222) This study 
pSM225 pAM450 containing 3 kb fragment from pSM224 This study 
pSM270 pCR2.1 containing 0.42 kb grlR ORF This study 
pSM272 0.84 kb fragment (0.42 kb grlR ORF and 0.42 kb 
sequence upstream of grlR-grlA) cloned in pCR2.1 This study 
aDetailed descriptions of bacterial strains and plasmids are discussed in Materials and 
Methods. 
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Table 2. Primers used for PCR and RT-PCR 
Primer Nucleotide sequence (5' - 3') Gene 
VS319 CCGTTGAAGTGAAAGACGGTC gapA 
VS320 AACCACTTTCTTCGCACCAGC gapA 
VS323 TGTGGATGCCAAAATTGCTG espA 
VS324 CGCCTTCACTGTTTGCAGATC espA 
VS376 AGTCCATCATCAGGCACATTAG /er ORF 
VS377 CATACAACAAGTCCCATACATTC fer ORF 
VS418 GGTGGATCCTGGCGAAAGCGAAAGTGACTG clpP 
VS419 GGTGGATCCCATCTTTGCGTTTATCTGTCATG clpP 
VS420 GGTGGATCCAACGAGCTGATGAACCAGCAG clpXP 
VS421 GGTGGATCCCATTCAACGCCGAGAATAGAG clpXP 
VS449 CATCTAGACTATTTGAATGCTTTCGGG clpXP 
VS450 CAGTCGACTCCATGCAAAATTCATG clpXP 
VS451 CAGTCGACCATACAATTAGTTAAC clpXP 
VS452 CATCTAGACAAGCAGTGCGGAAGC clpXP 
VS534 GATAGAACAAATTGAAAGGAGTG grlR 
VS535 CCGTCGACTTATTTTAAATAAACTTGTGGCATTCC grlR 
VS537 ACAGGCATCATTCAATAAATCATC grlR- L0045 intergenic region 
VS587 AATAAACTTGTGGCATTCCTGTGT grlR 
VS588 CCCTCGGTGCTAAACATTGAAC grlR 
VS589 CGGTTGTTCCAGGACTTTCTATC gr/A 
VS590 
46 
CTGAGGAGAGCATCATTTATTATAAC gr/A 
a Position of the primer sequence represents the location in the published sequence deposited 
under the indicated accession numbers at NCBI. Underlined sequences GGATCC, 
GTCGAC, and TCTAGA represent restriction sites BamHI, Sall, andXbal, respectively. 
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Fig. 1. Comparison of ~-galactosidase activity produced by the LEE4:: lac transcriptional 
fusion in various genetic backgrounds ofEHEC 0157:H7 strain 86-24 !J.stx2 /J.lac. Amounts 
of ~-galactosidase produced, as determined by OD6oo values and a liquid colorimetric assay, 
by each strain are shown as solid bar. Error bars represent standard deviations based on three 
measurements. 
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Fig. 2. Determination of the p-galactosidase activity of a EHEC 0157:H7 strain 86-241'1.hha 
!iclpXP and its derivative containing transposon-disrupted grlR with or without a plasmid 
providing grlR in trans. Amounts of p-galactosidase produced by each strain are shown as 
solid bars. Error bars represent standard deviations based on three measurements. 
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Figure 3 
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Fig. 3. RT-PCR-based determination of transcriptional levels of grlR-grlA in strains deleted 
of hha or clpXP or both. Amplification products generated by RT-PCR were resolved on 4% 
agarose gels containing ethidiurn bromide, and DNA bands were visualized using Alpha 
Innotech Image documentation system. Lanes 1-5, RT-PCR conducted in the presence of 8 x 
101, 8 x 10°, 8 x 10-1, 8 x 10-2, and 8 x 10-3 µg of total RNA; lanes: M, DNA size markers 
(size of marker bands is listed in on the left side). The arrow on the right shows the position 
of amplified products specific for grlR, and gr/A. 
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Fig. 4. Determination of transcriptional levels of LEE4 and ler using RT-PCR. Total RNA 
that was determined to be free of DNA contamination was diluted in a 10-fold serial dilution 
and used in RT-PCR assay to amplify and detect gapA-, LEE4- and /er-specific amplicons. 
The gapA was used as a control because the transcriptional level of this gene remain 
unaltered in mutant strains examined in this study. Equal volumes of amplified samples were 
resolved on 4% agarose gels containing ethidium bromide, and DNA bands were visualized 
using Alpha Innotech Image documentation system. Lanes 1-5, RT-PCR conducted in the 
presence of 8 x 101, 8 x 10°, 8 x 10-1, 8 x 10-2, and 8 x 10-3 µg of total RNA; lanes: M, DNA 
size markers (size of marker bands is listed in on the left side). The arrow on the right shows 
the position of amplified products specific for gapA, LEE4, and ler. 
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Figure 5 
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Fig. 5. Effect of clpXP deletion on intracellular levels of Hha. Cell-free extracts containing 
identical amounts of total proteins prepared were resolved on a 4-20% SDS-polyacrylamide 
gel. The resolved proteins were electroblotted to a nitrocellulose membrane, and the 
membrane, after treatment with a blocking solution, was incubated with rabbit anti-Hha 
polyclonal serum followed by incubation with a goat-anti-rabbit polyclonal antibodies 
conjugated to horseradish peroxidase. The specific binding of anti-Hha antibody was 
determined by visualization of purple bands at a position corresponding to the predicted size 
for Hha. Total proteins from strain VKS0I, VKS03, VKS02, and VKS04 were analyzed in 
lanel , 2, 3, and 4, respectively. Lane M contains molecular size (indicated as bp on the lefts 
side) markers. Arrow shows the position of Hha-specific signal. 
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Fig. 6. Diagrammatic representation of the ClpXP- and Hha-mediated regulation of !er and 
LEE expression in EHEC 0157:H7. A) This part of the model shows that by some unknown 
mechanism (?), ClpXP keeps Hha at concentrations that allow very low levels of 
transcription to proceed from promoters transcribing !er and grlR-grlA . Since GrlA (gr/A 
encoded protein) is not affected by ClpXP protease unlike GrlR (mechanism not known), 
increased amounts of GrlA would have an overall positive effect on !er transcription 
resulting in a steady state or low level of LEE expression. B) This part of the model shows 
that if Hha is not present in the cell ( due to hha deletion in this study) or its concentration 
become too low to repress !er and gr!R-gr!A , !er and LEE would be up-regulated because of 
increased amounts of GrlA. Transcriptional levels of gr!R would also be elevated, but ClpXP 
would keep GrlR at levels much lower than that of GrlA. 
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General Conclusions 
Enterohemorraghic Escherichia coli 0157:H7 is a major food borne pathogen which 
can lead to severe human disease. This strain in particular is a burden in the U. S. due to the 
difficulty in identifying and controlling the fecal shedding in our dairy and beef cattle herds. 
Multiple attempts at control have failed and with the expanding knowledge of molecular 
genetics we are opening doors to new methods of control and prevention. 
This study was designed to identify important and novel regulatory agents of LEE4. 
The experiment utilized transcriptional fusions to monitor the effects of gene knockouts and 
identified the ClpXP protease as a positive regulator of LEE4. Additional experiments 
yielded the identification of GrlR and Rep as potential substrates for the ClpXP protease. 
Unfortunately, before we could publish our work these results were reproduced and 
published by another group. The identification of potential substrates for ClpXP included 
proteins, Hha and GlrR which are negative regulators of LEE. Our laboratory previously 
identified Hha as a transcriptional regulator of LEE. Additional experiments and the 
correlation with YmoA of Yersinia pestis as a Hha homolog made Hha a probable target. We 
identified that in the absence of the ClpXP protease and the presence of other proteases such 
as Lon, the protein Hha accumulates. This finding is indicative of Hha as a potential substrate 
for the ClpXP protease system and further experiments are warranted. 
Upon completion of this paper, additional experiments were considered such as the 
use of crude protein extracts and digestion assays to identify Hha as a potential direct target 
for the ClpXP protease, 2-dimensional gel systems to compare protein distributions in parent 
and mutant strains (86-24~tx2 Mac, 13.clpXP, 13.hha, and 13.clpXP 13.hha) and microarray 
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systems to identify an overall view of genetic activity in parent and mutant strains. I see the 
use of these techniques in the future to better characterize the regulatory and modulatory 
effect of ClpXP in LEE ofEHEC 0157:H7. The information gained in these experiments 
will help contribute to the knowledge of LEE regulation in EHEC 0157:H7. The important 
discovery of ler in the modulation of virulence has lead to the potential production of 
vaccines (58). The more we learn about these regulatory cascades, the more efficient our 
attempts will be to reduce human exposure to EHEC 0157:H7. 
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